Skip to main content
. Author manuscript; available in PMC: 2021 Mar 8.
Published in final edited form as: J Rheumatol. 2019 Jul 1;47(8):1267–1274. doi: 10.3899/jrheum.190162

Table 2.

Pain symptoms reported by serologically confirmed CHIKV patients at 40 months post-infection classified by joint pain status.

Variables All CHIKV
Cases, n = 82
Persistent Joint
Pain, n = 67
No Persistent Joint
Pain, n = 15
p
Symptoms caused patient to miss work/school 31 (38) 27 (40) 4 (27) 0.33
Symptoms affecting capacity to continue normal activities 37 (47) 35 (54) 2 (14) 0.0071
Swollen joint count, mean ± SD 0.4 ± 0.9 0.4 ± 0.9 0.4 ± 0.9 0.90
Tender joint count, mean ± SD 5.2 ± 6.7 6.2 ± 7.1 0.7 ± 1.0 < 0.0001
Global pain score in the last week, mean ± SD (range 0–100) 56.8 ± 27.3 64.9 ± 20.3 20.7 ± 25.2 < 0.0001
Developed rheumatoid arthritis after CHIKV infection 2 (2) 2 (3) 0 (0) 0.50
Developed osteoarthritis after CHIKV infection 19 (23) 17 (25) 2 (13) 0.32
Developed depression after CHIKV infection 9 (11) 6 (9) 3 (20) 0.22

Values are n (%) unless otherwise indicated.

Data were not available for all patients.

Nonparametric Wilcoxon rank-sum test. Values in bold face are statistically significant. CHIKV: chikungunya virus.